Feasibility of Improving Sleep Apnea Treatment Adherence After Brain Injury
FISATABI
Improving Sleep Apnea Treatment Adherence After Brain Injury: A Feasibility Study
1 other identifier
interventional
17
1 country
1
Brief Summary
Background: Obstructive sleep apnea (OSA) is a sleep disorder common among Veterans with moderate-to-severe traumatic brain injury (TBI). Untreated OSA increases risk of poor health outcomes including cognitive impairment, declining mental and physical health, and premature mortality. Positive airway pressure (PAP) is the frontline treatment for OSA that effectively reduces many negative health consequences of the disease. Unfortunately, PAP adherence is poor. A recent study showed that 68% of Veterans with moderate-to-severe TBI and OSA were nonadherent to PAP therapy. Psychoeducation is the standard of care for OSA treatment with PAP, but on its own is insufficient for improving adherence. Alternatives to the standard of care include evidence-based behavioral interventions such as Motivational Interviewing (MI) and Cognitive-Behavioral Therapy (CBT) which have been shown to improve PAP adherence in general sleep clinic samples. Unfortunately, these evidence-based interventions (designed for cognitively intact individuals) have not been adapted to address PAP adherence in persons with moderate-to-severe TBI, who often require cognitive accommodations. The goal of this study is to test the feasibility of a novel manualized intervention, designed with cognitive accommodations, and informed by MI and CBT, to address PAP adherence in Veterans with TBI and OSA. Study Aims: Study Aim 1 tested the feasibility and acceptability of delivering the PAP adherence intervention. Study Aim 2 evaluated the feasibility of outcome and process measures. Method: Veterans were recruited from inpatient and outpatient TBI and sleep clinics. Those meeting eligibility criteria (diagnosis of OSA and moderate-to-severe TBI; nonadherent to PAP, able to provide informed consent) were invited to participate in the 4-session intervention followed by a qualitative interview to inquire about intervention acceptability. Study measures (e.g., symptom severity, sleep quality of life), will be administered pre- and post-intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 6, 2020
CompletedFirst Posted
Study publicly available on registry
January 7, 2020
CompletedStudy Start
First participant enrolled
August 3, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedResults Posted
Study results publicly available
July 8, 2024
CompletedJuly 8, 2024
March 1, 2024
1.7 years
January 6, 2020
February 10, 2023
March 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Narrative Evaluation of Intervention Interview (Post-intervention Qualitative Interview)
The Narrative Evaluation of Intervention Interview is a 16-item semi-structured interview that elicits participant feedback about an intervention. The data yielded by the NEII are qualitative, using qualitative thematic analysis. All 13 participants who completed the study also completed the NEII interview.
Post-intervention (up to 8 weeks after completion of the single arm intervention)
Secondary Outcomes (3)
Epworth Sleepiness Scale
Single time point, following completion of the single arm intervention, up to 12 weeks post-intervention
Fatigue Severity Scale
Single time point, following completion of the single arm intervention, up to 12 weeks post-intervention
Functional Outcomes of Sleep Questionnaire
Single time point, following completion of the single arm intervention, up to 12 weeks post-intervention
Study Arms (1)
Intervention (single arm)
EXPERIMENTALThis is a 4-session intervention derived from Motivational Interviewing and Cognitive Behavior Therapy and adapted with cognitive accommodations.
Interventions
This is a 4-session intervention derived from Motivational Interviewing and Cognitive Behavior Therapy and adapted with cognitive accommodations.
Eligibility Criteria
You may qualify if:
- moderate-to-severe TBI consistent
- diagnosed with OSA and prescribed PAP therapy
- nonadherent to PAP treatment
- are able to consent.
You may not qualify if:
- mild only TBI
- no TBI
- no OSA
- not prescribed PAP therapy
- adherent to PAP therapy (6) unable to provide consent on own behalf
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
James A. Haley Veterans' Hospital, Tampa, FL
Tampa, Florida, 33612, United States
Related Publications (1)
Silva MA, Arriola NB, Radwan CK, Womble BM, Healey EA, Lee JM, Aloia MS, Nakase-Richardson R. Improving sleep apnea treatment adherence after traumatic brain injury: A nonrandomized feasibility study. Rehabil Psychol. 2022 Nov;67(4):461-473. doi: 10.1037/rep0000473.
PMID: 36355639DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Marc A Silva
- Organization
- James A Haley Veterans' Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Marc A Silva, PhD
James A. Haley Veterans' Hospital, Tampa, FL
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 6, 2020
First Posted
January 7, 2020
Study Start
August 3, 2020
Primary Completion
March 31, 2022
Study Completion
June 30, 2022
Last Updated
July 8, 2024
Results First Posted
July 8, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Will be available starting twelve months following publication of study findings.
- Access Criteria
- Data are not publicly available. Information will be shared by contacting the study PI and upon institutional approval.
A Limited Dataset (LDS) will be created and shared pursuant to a Data Use Agreement (DUA) appropriately limiting use of the dataset and prohibiting the recipient from identifying or re-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset.